| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Southfield, Mich., Oct. 22, 2025 – Corewell Health physicians are researching cancer treatment advancements with a new $2.2 million grant from the National Institutes of Health. The four-year...
Matthew Sims, M.D., Ph.D., FACP, FIDSA, currently the director of infectious diseases research at Corewell Health, will assume the role of the inaugural Corewell Health East research medical...
Grand Rapids, Mich., May 15, 2025 – A new study that is the first to compare inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows...
Southfield, Mich., April 23, 2025 – For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating...
Grand Rapids, Mich., Nov. 21, 2024 – For 17 years, Corewell Health in Grand Rapids, Michigan, and Michigan State University College of Human Medicine have funded more than $27 million in...
To make a transformative difference for leukemia research at Corewell Health in Southeast Michigan. An extraordinary bequest from the estate of Harry Kirk Denler will make a game-changing impact...
Grand Rapids, Mich., Sept. 9, 2024 – For the past three years, Corewell Health™ researchers have been studying the genetic code of the virus that causes COVID-19 to better understand how it is...
Corewell Health and MSU look to develop AI tool to identify higher-risk patients earlier SOUTHFIELD, MI, Aug. 12, 2024 - Corewell Healthâ„¢ and Michigan State University researchers are the first...
New Corewell Healthâ„¢ research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire...
For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes...